{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:54:38Z","timestamp":1790013278081,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:00:00Z","timestamp":1555372800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00277-019-03669-z","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T11:03:01Z","timestamp":1555412581000},"page":"1755-1763","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT"],"prefix":"10.1007","volume":"98","author":[{"given":"Martin","family":"Schmidt-Hieber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Tridello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Ljungman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Mikulska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Knelange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Blaise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Soci\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liisa","family":"Volin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Blijlevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Fegueux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Yakoub-Agha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Forcade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Maertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Chevallier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Passweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Cornelissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Craddock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Henri","family":"Bourhis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Marchand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Rem\u00e9nyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Yves","family":"Cahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricette","family":"Michallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Montoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaus","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram","family":"Gla\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Styczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,16]]},"reference":[{"issue":"19","key":"3669_CR1","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1182\/blood-2013-05-499830","volume":"122","author":"M Schmidt-Hieber","year":"2013","unstructured":"Schmidt-Hieber M, Labopin M, Beelen D, Volin L, Ehninger G, Finke J, Soci\u00e9 G, Schwerdtfeger R, Kr\u00f6ger N, Ganser A, Niederwieser D, Polge E, Blau IW, Mohty M (2013) CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT. Blood 122(19):3359\u20133364. \n                    https:\/\/doi.org\/10.1182\/blood-2013-05-499830","journal-title":"Blood"},{"issue":"6","key":"3669_CR2","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.bbmt.2011.10.037","volume":"18","author":"JE Jang","year":"2012","unstructured":"Jang JE, Hyun SY, Kim YD, Yoon SH, Hwang DY, Kim SJ, Kim Y, Kim JS, Cheong JW, Min YH (2012) Risk factors for progression from cytomegalovirus viremia to cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 18(6):881\u2013886. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2011.10.037","journal-title":"Biol Blood Marrow Transplant"},{"issue":"13","key":"3669_CR3","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMoa1303688","volume":"369","author":"FM Marty","year":"2013","unstructured":"Marty FM, Winston DJ, Rowley SD, Vance E, Papanicolaou GA, Mullane KM, Brundage TM, Robertson AT, Godkin S, Momm\u00e9ja-Marin H, Boeckh M (2013) CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation. N Engl J Med 369(13):1227\u20131236. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1303688","journal-title":"N Engl J Med"},{"issue":"19","key":"3669_CR4","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJMoa1309533","volume":"370","author":"RF Chemaly","year":"2014","unstructured":"Chemaly RF, Ullmann AJ, Stoelben S, Richard MP, Bornh\u00e4user M, Groth C, Einsele H, Silverman M, Mullane KM, Brown J, Nowak H, K\u00f6lling K, Stobernack HP, Lischka P, Zimmermann H, R\u00fcbsamen-Schaeff H, Champlin RE, Ehninger G (2014) Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation. N Engl J Med 370(19):1781\u20131789. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1309533","journal-title":"N Engl J Med"},{"issue":"3","key":"3669_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S2352-3026(15)00289-6","volume":"3","author":"ML Green","year":"2016","unstructured":"Green ML, Leisenring W, Xie H, Mast TC, Cui Y, Sandmaier BM, Sorror ML, Goyal S, \u00d6zk\u00f6k S, Yi J, Sahoo F, Kimball LE, Jerome KR, Marks MA, Boeckh M (2016) Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study. Lancet Haematol 3(3):27\u2013e127. \n                    https:\/\/doi.org\/10.1016\/S2352-3026(15)00289-6","journal-title":"Lancet Haematol"},{"issue":"25","key":"3669_CR6","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","volume":"377","author":"FM Marty","year":"2017","unstructured":"Marty FM, Ljungman P, Chemaly RF, Maertens J, Dadwal SS, Duarte RF, Haider S, Ullmann AJ, Katayama Y, Brown J, Mullane KM, Boeckh M, Blumberg EA, Einsele H, Snydman DR, Kanda Y, DiNubile MJ, Teal VL, Wan H, Murata Y, Kartsonis NA, Leavitt RY, Badshah C (2017) Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation. N Engl J Med 377(25):2433\u20132444. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1706640","journal-title":"N Engl J Med"},{"issue":"7","key":"3669_CR7","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood.V95.7.2240","volume":"95","author":"AE Broers","year":"2000","unstructured":"Broers AE, van der Holt R, van Esser JW, Gratama JW, Henzen-Logmans S, Kuenen-Boumeester V, L\u00f6wenberg B, Cornelissen JJ (2000) Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation. Blood 95(7):2240\u20132245","journal-title":"Blood"},{"issue":"4","key":"3669_CR8","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1046\/j.1365-2141.2001.02849.x","volume":"113","author":"N Kr\u00f6ger","year":"2001","unstructured":"Kr\u00f6ger N, Zabelina T, Kr\u00fcger W, Renges H, Stute N, Schrum J, Kabisch H, Schafhausen P, Jaburg N, L\u00f6liger C, Sch\u00e4fer P, Hinke A, Zander AR (2001) Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulin. Br J Haematol 113(4):1060\u20131071","journal-title":"Br J Haematol"},{"issue":"3","key":"3669_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1086\/338624","volume":"185","author":"WG Nichols","year":"2002","unstructured":"Nichols WG, Corey L, Gooley T, Davis C, Boeckh M (2002) High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. J Infect Dis 185(3):273\u2013282. \n                    https:\/\/doi.org\/10.1086\/338624","journal-title":"J Infect Dis"},{"issue":"11","key":"3669_CR10","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.bbmt.2017.07.025","volume":"23","author":"MK Yong","year":"2017","unstructured":"Yong MK, Ananda-Rajah M, Cameron PU, Morrissey CO, Spencer A, Ritchie D, Cheng AC, Lewin SR, Slavin M (2017) Cytomegalovirus reactivation is associated with increased risk of late-onset invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a multicenter study in the current era of viral load monitoring. Biol Blood Marrow Transplant 23(11):1961\u20131967. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2017.07.025","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"3669_CR11","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/j.1365-2141.1986.tb07551.x","volume":"63","author":"B L\u00f6nnqvist","year":"1986","unstructured":"L\u00f6nnqvist B, Ringd\u00e8n O, Ljungman P, Wahren B, Gahrton G (1986) Reduced risk of recurrent leukaemia in bone marrow transplant recipients after cytomegalovirus infection. Br J Haematol 63(4):671\u2013679","journal-title":"Br J Haematol"},{"issue":"5","key":"3669_CR12","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1182\/blood-2010-08-304121","volume":"118","author":"AH Elmaagacli","year":"2011","unstructured":"Elmaagacli AH, Steckel NK, Koldehoff M, Hegerfeldt Y, Trenschel R, Ditschkowski M, Christoph S, Gromke T, Kordelas L, Ottinger HD, Ross RS, Horn PA, Schnittger S, Beelen DW (2011) Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients. Blood 118(5):1402\u20131412. \n                    https:\/\/doi.org\/10.1182\/blood-2010-08-304121","journal-title":"Blood"},{"issue":"7","key":"3669_CR13","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1182\/blood-2013-02-487074","volume":"122","author":"ML Green","year":"2013","unstructured":"Green ML, Leisenring WM, Xie H, Walter RB, Mielcarek M, Sandmaier BM, Riddell SR, Boeckh M (2013) CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia. Blood 122(7):1316\u20131324. \n                    https:\/\/doi.org\/10.1182\/blood-2013-02-487074","journal-title":"Blood"},{"issue":"4","key":"3669_CR14","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1399-3062.2010.00504.x","volume":"12","author":"B George","year":"2010","unstructured":"George B, Pati N, Gilroy N, Ratnamohan M, Huang G, Kerridge I, Hertzberg M, Gottlieb D, Bradstock K (2010) Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy. Transpl Infect Dis 12(4):322\u2013329. \n                    https:\/\/doi.org\/10.1111\/j.1399-3062.2010.00504.x","journal-title":"Transpl Infect Dis"},{"issue":"7","key":"3669_CR15","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1182\/blood-2013-06-508515","volume":"122","author":"P Ljungman","year":"2013","unstructured":"Ljungman P (2013) CMV: a warrior against leukemia? Blood 122(7):1101\u20131102. \n                    https:\/\/doi.org\/10.1182\/blood-2013-06-508515","journal-title":"Blood"},{"issue":"20","key":"3669_CR16","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1182\/blood-2015-11-679639","volume":"127","author":"P Teira","year":"2016","unstructured":"Teira P, Battiwalla M, Ramanathan M, Barrett AJ, Ahn KW, Chen M, Green JS, Saad A, Antin JH, Savani BN, Lazarus HM, Seftel M, Saber W, Marks D, Aljurf M, Norkin M, Wingard JR, Lindemans CA, Boeckh M, Riches ML, Auletta JJ (2016) Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis. Blood 127(20):2427\u20132438. \n                    https:\/\/doi.org\/10.1182\/blood-2015-11-679639","journal-title":"Blood"},{"issue":"4","key":"3669_CR17","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1080\/10428194.2016.1217524","volume":"58","author":"M Koldehoff","year":"2017","unstructured":"Koldehoff M, Ross SR, D\u00fchrsen U, Beelen DW, Elmaagacli AH (2017) Early CMV-replication after allogeneic stem cell transplantation is associated with a reduced relapse risk in lymphoma. Leuk Lymphoma 58(4):822\u2013833. \n                    https:\/\/doi.org\/10.1080\/10428194.2016.1217524","journal-title":"Leuk Lymphoma"},{"issue":"13","key":"3669_CR18","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1182\/blood-2006-04-020313","volume":"108","author":"MS Albano","year":"2006","unstructured":"Albano MS, Taylor P, Pass RF, Scaradavou A, Ciubotariu R, Carrier C, Dobrila L, Rubinstein P, Stevens CE (2006) Umbilical cord blood transplantation and cytomegalovirus: posttransplantation infection and donor screening. Blood 108(13):4275\u20134282. \n                    https:\/\/doi.org\/10.1182\/blood-2006-04-020313","journal-title":"Blood"},{"issue":"1","key":"3669_CR19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.bbmt.2011.05.015","volume":"18","author":"M Mikulska","year":"2012","unstructured":"Mikulska M, Raiola AM, Bruzzi P, Varaldo R, Annunziata S, Lamparelli T, Frassoni F, Tedone E, Galano B, Bacigalupo A, Viscoli C (2012) CMV infection after transplant from cord blood compared to other alternative donors: the importance of donor-negative CMV serostatus. Biol Blood Marrow Transplant 18(1):92\u201399. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2011.05.015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"3669_CR20","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/bmt.2013.73","volume":"48","author":"HW Auner","year":"2013","unstructured":"Auner HW, Szydlo R, van Biezen A, Iacobelli S, Gahrton G, Milpied N, Volin L, Janssen J, Nguyen Quoc S, Michallet M, Schoemans H, El Cheikh J, Petersen E, Guilhot F, Sch\u00f6nland S, Ahlberg L, Morris C, Garderet L, de Witte T, Kr\u00f6ger N (2013) Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 48(11):1395\u20131400. \n                    https:\/\/doi.org\/10.1038\/bmt.2013.73","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"3669_CR21","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1038\/leu.2014.145","volume":"28","author":"M Stern","year":"2014","unstructured":"Stern M, de Wreede LC, Brand R, van Biezen A, Dreger P, Mohty M, de Witte TM, Kr\u00f6ger N, Ruutu T (2014) Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysis. Leukemia 28(11):2235\u20132240. \n                    https:\/\/doi.org\/10.1038\/leu.2014.145","journal-title":"Leukemia"},{"key":"3669_CR22","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/annonc\/mdw124","volume":"27","author":"SP Robinson","year":"2016","unstructured":"Robinson SP, Boumendil A, Finel H, Schouten H, Ehninger G, Maertens J, Crawley C, Rambaldi A, Russell N, Anders W, Blaise D, Yakoub-Agha I, Ganser A, Castagna L, Volin L, Cahn JY, Montoto S, Dreger P (2016) Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long term disease control: an analysis from the Lymphoma Working Party of the EBMT. Ann Oncol 27:1088\u20131094. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdw124","journal-title":"Ann Oncol"},{"issue":"8","key":"3669_CR23","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/bmt.2017.19","volume":"52","author":"R Martino","year":"2017","unstructured":"Martino R, Henseler A, van Lint M, Schaap N, Finke J, Beelen D, Vigouroux S, Alessandrino EP, Mufti GJ, Veelken JH, Bruno B, Yakoub-Agha I, Volin L, Maertens J, Or R, Leblond V, Rovira M, Kalhs P, Alvarez AF, Vitek A, Sierra J, Wagner E, Robin M, de Witte T, Kr\u00f6ger N (2017) Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes. Bone Marrow Transplant 52(8):1107\u20131112. \n                    https:\/\/doi.org\/10.1038\/bmt.2017.19","journal-title":"Bone Marrow Transplant"},{"key":"3669_CR24","first-page":"515","volume-title":"Hematopoietic Cell Transplantation","author":"KM Sullivan","year":"1999","unstructured":"Sullivan KM (1999) Graft-versus-host-disease. In: Thomas E, Blume K, Forman SJ (eds) Hematopoietic Cell Transplantation, 2nd edn. Blackwell Science, Boston, MA, pp 515\u2013526","edition":"2"},{"issue":"6","key":"3669_CR25","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/MOH.0000000000000085","volume":"21","author":"P Ljungman","year":"2014","unstructured":"Ljungman P (2014) The role of cytomegalovirus serostatus on outcome of hematopoietic stem cell transplantation. Curr Opin Hematol 21(6):466\u2013469. \n                    https:\/\/doi.org\/10.1097\/MOH.0000000000000085","journal-title":"Curr Opin Hematol"},{"issue":"4","key":"3669_CR26","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/cid\/ciu364","volume":"59","author":"P Ljungman","year":"2014","unstructured":"Ljungman P, Brand R, Hoek J, de La CR, Cordonnier C, Einsele H, Styczynski J, Ward KN, Cesaro S (2014) Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantation. Clin Infect Dis 59(4):473\u2013481. \n                    https:\/\/doi.org\/10.1093\/cid\/ciu364","journal-title":"Clin Infect Dis"},{"issue":"8","key":"3669_CR27","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3324\/haematol.11061","volume":"92","author":"P Ljungman","year":"2007","unstructured":"Ljungman P, Brandan R (2007) Factors influencing cytomegalovirus seropositivity in stem cell transplant patients and donors. Haematologica 92(8):1139\u20131142","journal-title":"Haematologica"},{"issue":"5","key":"3669_CR28","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3324\/haematol.2014.115345","volume":"100","author":"A Bacigalupo","year":"2015","unstructured":"Bacigalupo A, Soci\u00e9 G, Hamladji RM, Aljurf M, Maschan A, Kyrcz-Krzemien S, Cybicka A, Sengelov H, Unal A, Beelen D, Locasciulli A, Dufour C, Passweg JR, Oneto R, Signori A, Marsh JCW (2015) Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis. Haematologica 100(5):696\u2013702. \n                    https:\/\/doi.org\/10.3324\/haematol.2014.115345","journal-title":"Haematologica"},{"issue":"10","key":"3669_CR29","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.2217\/imt.15.70","volume":"7","author":"T Nishihori","year":"2015","unstructured":"Nishihori T, Shaheen M, El-Asmar J, Aljurf M, Kharfan-Dabaja MA (2015) Therapeutic strategies for cytomegalovirus in allogeneic hematopoietic cell transplantation. Immunotherapy 7(10):1059\u20131071. \n                    https:\/\/doi.org\/10.2217\/imt.15.70","journal-title":"Immunotherapy"},{"issue":"6","key":"3669_CR30","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1080\/17474086.2016.1174571","volume":"9","author":"E Maffini","year":"2016","unstructured":"Maffini E, Giaccone L, Festuccia M, Brunello L, Busca A, Bruno B (2016) Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation. Expert Rev Hematol 9(6):585\u2013596. \n                    https:\/\/doi.org\/10.1080\/17474086.2016.1174571","journal-title":"Expert Rev Hematol"},{"issue":"6","key":"3669_CR31","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/sj.bmt.1701139","volume":"21","author":"D Gor","year":"1998","unstructured":"Gor D, Sabin C, Prentice HG, Vyas N, Man S, Griffiths PD, Emery VC (1998) Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor\/recipient serostatus, acute GVHD and CMV disease. Bone Marrow Transplant 21(6):597\u2013605. \n                    https:\/\/doi.org\/10.1038\/sj.bmt.1701139","journal-title":"Bone Marrow Transplant"},{"key":"3669_CR32","doi-asserted-by":"crossref","unstructured":"Ganepola S, Gentilini C, Hilbers U, Lange T, Rieger K, Hofmann J, Maier M, Liebert UG, Niederwieser D, Engelmann E, Heilbronn R, Thiel E, Uharek L (2007) Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation. Bone Marrow Transplant 39:293\u2013299","DOI":"10.1038\/sj.bmt.1705585"},{"key":"3669_CR33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.trim.2018.04.003","volume":"49","author":"PLJ Heiden van der","year":"2018","unstructured":"van der Heiden PLJ, van Egmond HM, Veld SAJ, van de Meent M, Eefting M, de Wreede LC, Halkes CJM, Falkenburg JHF, Marijt WAF, Jedema I (2018) CMV seronegative donors: effect on clinical severity of CMV infection and reconstitution of CMV-specific immunity. Transpl Immunol 49:54\u201358. \n                    https:\/\/doi.org\/10.1016\/j.trim.2018.04.003","journal-title":"Transpl Immunol"},{"issue":"10","key":"3669_CR34","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.bbmt.2016.07.009","volume":"22","author":"FM Verduyn Lunel","year":"2016","unstructured":"Verduyn Lunel FM, Raymakers R, van Dijk A, van der Wagen L, Minnema MC, Kuball J (2016) Cytomegalovirus status and the outcome of T cell-replete reduced-intensity allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 22(10):1883\u20131887. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2016.07.009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"3669_CR35","first-page":"1062","volume":"13","author":"O Ringd\u00e9n","year":"1985","unstructured":"Ringd\u00e9n O, Paulin T, L\u00f6nnqvist B, Nilsson B (1985) An analysis of factors predisposing to chronic graft-versus-host disease. Exp Hematol 13(10):1062\u20131067","journal-title":"Exp Hematol"},{"issue":"4","key":"3669_CR36","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1182\/blood.V67.4.1162.1162","volume":"67","author":"W Miller","year":"1986","unstructured":"Miller W, Flynn P, McCullough J, Balfour HH, Goldman A, Haake R, McGlave P, Ramsay N, Kersey J (1986) Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease. Blood 67(4):1162\u20131167","journal-title":"Blood"},{"issue":"6","key":"3669_CR37","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1182\/blood-2003-10-3616","volume":"103","author":"M Boeckh","year":"2004","unstructured":"Boeckh M, Nichols WG (2004) The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy. Blood 103(6):2003\u20132008. \n                    https:\/\/doi.org\/10.1182\/blood-2003-10-3616","journal-title":"Blood"},{"issue":"36","key":"3669_CR38","doi-asserted-by":"publisher","first-page":"5695","DOI":"10.1200\/JCO.2006.08.0952","volume":"24","author":"I Yakoub-Agha","year":"2006","unstructured":"Yakoub-Agha I, Mesnil F, Kuentz M, Boiron JM, Ifrah N, Milpied N, Chehata S, Esperou H, Vernant JP, Michallet M, Buzyn A, Gratecos N, Cahn JY, Bourhis JH, Chir Z, Raffoux C, Soci\u00e9 G, Golmard JL, Jouet JP (2006) Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10\/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy. J Clin Oncol 24(36):5695\u20135702. \n                    https:\/\/doi.org\/10.1200\/JCO.2006.08.0952","journal-title":"J Clin Oncol"},{"issue":"35","key":"3669_CR39","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.1200\/JCO.2008.17.6545","volume":"26","author":"T Hahn","year":"2008","unstructured":"Hahn T, McCarthy PL, Zhang M-J, Wang D, Arora M, Frangoul H, Gale RP, Hale GA, Horan J, Isola L, Maziarz RT, van Rood JJ, Gupta V, Halter J, Reddy V, Tiberghien P, Litzow M, Anasetti C, Pavletic S, Ringd\u00e9n O (2008) Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia. J Clin Oncol 26(35):5728\u20135734. \n                    https:\/\/doi.org\/10.1200\/JCO.2008.17.6545","journal-title":"J Clin Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03669-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-019-03669-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03669-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T23:04:04Z","timestamp":1586905444000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-019-03669-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,16]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["3669"],"URL":"https:\/\/doi.org\/10.1007\/s00277-019-03669-z","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,16]]},"assertion":[{"value":"9 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"I.Y.A received honorarium from Biotest and MSD Sharp & Dohme GmbH that commercialize anti-CMV drugs. The other authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"According to EBMT policy, patients give informed consent for data reporting to the EBMT registry.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}